AzTrials
AzTrials

Cardiac Arrest (CA)NCT07918391

CAROTID DOPPLER AND CEREBRAL OXIMERY IN POST CARDIAC ARREST ICU PATIENTS

An observational study of Cardiac Arrest (CA) and Carotid Doppler, run by Inonu University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Out-of-hospital cardiac arrest (OHCA) is one of the most critical conditions in emergency medicine, causing high mortality and severe neurological sequelae due to the sudden cessation of circulation. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cardiac Arrest (CA), Carotid Doppler
What is being tested?
Carotid Doppler Ultrasonography, Transcranial Doppler, Optic Nerve Sheath Diameter Measurement, and Cerebral Oximetry
How many people
28 participants
Where
No sites listed yet
Study dates
1 Nov 2026to 30 Dec 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients admitted to the intensive care unit after out-of-hospital cardiac arrest.

Who may be able to join

  • Age 18 years or older Admitted to the ICU after out-of-hospital cardiac arrest Hemodynamically stable PaCO2 35-45 mmHg

Who cannot join

  • Age under 18 years In-hospital cardiac arrest Anatomical abnormalities or skin lesions preventing carotid or cerebral ultrasonographic measurement Hemodynamic instability

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Ayşe Belin Özer, MD contact

+905534478924

belin.ozer@inonu.edu.tr

Beyza Alkayış, MD contact

+905538816020

beyza.alkayis@inonu.edu.tr

About this study

Official title: EFFECTS OF CAROTID DOPPLER ULTRASONOGRAPHY AND CEREBRAL OXIMETRY ON SURVIVAL AND NEUROLOGICAL OUTCOMES IN PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT FOLLOWING OUT OF HOSPITAL CARDIAC ARREST

Out-of-hospital cardiac arrest (OHCA) is one of the most critical conditions in emergency medicine, causing high mortality and severe neurological sequelae due to the sudden cessation of circulation. Among the hundreds of thousands of patients affected worldwide, a significant proportion die or face permanent neurological impairment from hypoxic-ischemic brain injury, even after return of spontaneous circulation (ROSC). Therefore, early and reliable assessment of brain injury after cardiac arrest is of great importance both for clinical decision-making and for the effective use of treatment resources.

Various methods are currently used to predict neurological prognosis after cardiac arrest, including computed tomography, magnetic resonance imaging, electroencephalography, and biochemical markers (NSE, S100B). However, some of these methods are expensive, have limited availability, or can be difficult to apply in the management of critically ill patients. In this context, bedside ultrasonography and cerebral oximetry, being applicable at the bedside, non-invasive, and repeatable, stand out as valuable alternative tools for clinicians.

Read more

Carotid Doppler ultrasonography provides indirect information about cerebral perfusion by measuring parameters such as peak systolic velocity (PSV), end-diastolic velocity (EDV), mean velocity (MV), pulsatility index (PI), and resistive index (RI) in the common carotid arteries. High PI and RI values indicate increased intracranial pressure or impaired cerebral vasomotor response, and these findings may be associated with poor neurological outcome. Similarly, transcranial Doppler (TCD) performed via the transtemporal approach reflects the integrity of cerebral autoregulation and cerebral perfusion pressure through middle cerebral artery (MCA) flow velocities and pulsatility values.

Optic nerve sheath diameter (ONSD) measurement is an increasingly widespread ultrasound application serving as a non-invasive indicator of elevated intracranial pressure. The optic nerve sheath is known to widen in the presence of cerebral edema, and this finding is thought to be associated with neurological deterioration.

Non-invasive cerebral oximetry (rSO2) continuously monitors frontal cerebral oxygen saturation, allowing early detection of periods of cerebral hypoxia. Inadequate cerebral oxygenation after cardiac arrest has been shown to be directly associated with poor prognosis. However, comprehensive studies interpreting this parameter together with Doppler ultrasonography findings are still lacking.

The primary aim of this study is to prospectively investigate the predictive value of carotid Doppler (internal, external, and common carotid arteries), TCD-MCA, and ONSD measurements, together with non-invasive cerebral oximetry values, for 60-day mortality and neurological outcome (Cerebral Performance Category, CPC scale) in patients admitted to the ICU due to OHCA. Secondary aims include examining the correlations between these parameters and determining the earliest and most reliable prognostic cut-off values.

The results of this study are expected to contribute to early neurological prognostication and patient management in ICU patients after OHCA

Being tested
Carotid Doppler Ultrasonography, Transcranial Doppler, Optic Nerve Sheath Diameter Measurement, and Cerebral Oximetry
Keywords
transcranial doppler ultrasonography, carotid doppler, pulsatility index, resistive index, cerebral hemodynamics, cerebral oximetry
Medical subject headings
Heart Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Carotid Doppler Ultrasonography, Transcranial Doppler, Optic Nerve Sheath Diameter Measurement, and Cerebral OximetryDiagnostic test

    Non-invasive bedside measurements performed alongside routine ICU care. Carotid Doppler ultrasonography (internal, external, and common carotid arteries) records peak systolic velocity, end-diastolic velocity, mean velocity, pulsatility index, and resistive index. Transcranial Doppler of the middle cerebral artery and optic nerve sheath diameter are measured within the first 24 hours, at 72 hours, and on days 5-7 after ICU admission. Cerebral oxygen saturation (rSO2) is monitored continuously with near-infrared spectroscopy during the first 72 hours, with the lowest and mean values recorded every 6 hours.

Study groups in NCT07918391
Study groupRoleWhat they receive
Adult OHCA Patients Admitted to the ICU GroupAdult patients (≥18 years) admitted to the intensive care unit after out-of-hospital cardiac arrest who are hemodynamically stable with PaCO2 35-45 mmHg. Carotid Doppler, transcranial Doppler (MCA), and optic nerve sheath diameter are measured within the first 24 hours, at 72 hours, and on days 5-7. Cerebral oximetry (rSO2) is monitored continuously during the first 72 hours.
Receives: Diagnostic Test: Carotid Doppler Ultrasonography, Transcranial Doppler, Optic Nerve Sheath Diameter Measurement, and Cerebral Oximetry

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Association Between Carotid Doppler Indices and Neurological Outcome (CPC) After Out-of-Hospital Cardiac Arrest

    Pulsatility index and resistive index of the internal, external, and common carotid arteries, measured within the first 24 hours, at 72 hours, and on days 5-7 after ICU admission, will be analyzed for their association with neurological outcome assessed by the Cerebral Performance Category (CPC) scale.

    Measured: 60 days after ICU admission

Secondary outcomes (3)
  1. Association Between Carotid Doppler Indices and Mortality After Out-of-Hospital Cardiac Arrest

    Peak systolic velocity, end-diastolic velocity, mean velocity, pulsatility index, and resistive index of the internal, external, and common carotid arteries, measured within the first 24 hours, at 72 hours, and on days 5-7 after ICU admission, will be analyzed for their association with all-cause mortality.

    Measured: 60 days after ICU admission

  2. Association Between Optic Nerve Sheath Diameter and Neurological Outcome and Mortality

    Optic nerve sheath diameter measured by ultrasonography within the first 24 hours, at 72 hours, and on days 5-7 will be analyzed for its association with CPC-based neurological outcome and mortality.

    Measured: 60 days after ICU admission

  3. Association Between Cerebral Oximetry (rSO2) and Neurological Outcome and Mortality

    Lowest and mean regional cerebral oxygen saturation (rSO2) values recorded every 6 hours during the first 72 hours of ICU stay, measured by near-infrared spectroscopy, will be analyzed for their association with CPC-based neurological outcome and mortality.

    Measured: First 72 hours of ICU stay for measurement; outcomes assessed at 60 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Nov 2026
  2. Study start1 Nov 2026 (estimated)
  3. Primary completion1 Dec 2027 (estimated)
  4. Study completion30 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
28 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07918391
Sponsor's protocol ID
10369
Status last verified
Nov 2026
First submitted
1 Nov 2026
Last updated
5 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared because patient data are anonymously coded and will not be shared with third parties, in line with the ethics committee approval. Aggregate results will be published in a peer-reviewed journal.

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiac Arrest (CA) and Carotid Doppler, run by Inonu University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 5 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ayşe Belin Özer, MD (+905534478924, belin.ozer@inonu.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Association Between Carotid Doppler Indices and Neurological Outcome (CPC) After Out-of-Hospital Cardiac Arrest (time frame: 60 days after ICU admission). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in